damnmaxims
@pharmalpha I am long on my $VVUS, no matter the Q1 EPS results. Qnexa has a chance of FDA approval and Vivus is planning on it
View Conversation
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.